Trial intelligence / Profile preview

Keplat versus Flector patch for knee osteoarthritis pain

2013-000334-36Phase 4Completed

Sponsor
Sager Pharma
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ketoprofen and diclofenac in knee osteoarthritis (OA) (2 arms), sponsored by Sager Pharma. Primary endpoint: Effectiveness in treatment of pain caused by osteoarthritis of the knee. Started Feb 2013; status: completed.

02

Drugs

ketoprofendiclofenac
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2013-000334-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000334-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call